ADORA2A and Parkinson disease: The significant role of human adenosine A2A receptor and dopamine D2 receptor in the pathogenesis of PD, together with emerging paradigm of drug actions on multiple receptors has spurred the discovery of new compounds to modulate both G protein-coupled receptors.